UnitedHealth aids Mayo Clinic's COVID-19 plasma study

Listen
Text
  • Small
  • Medium
  • Large

A COVID-19 plasma treatment study led by Rochester, Minn.-based Mayo Clinic will get funding from UnitedHealth Group to help accelerate the federally sponsored program.

The clinical initiative aims to coordinate blood plasma collection from recently recovered COVID-19 patients and use the plasma to treat hospital patients with severe COVID-19 infections. 

Mayo Clinic is coordinating efforts across 1,600-plus sites nationwide. So far, more than 600 patients have received convalescent plasma treatment. 

UnitedHealth's $5 million donation to the effort brings its COVID-19 donations up to $70 million to date. 

 

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars